Genzyme Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 45 New York Avenue, Framingham, Massachusetts (MA) 01701, United States (USA)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 1220423 · DUNS 968278916
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-09
- OAIDrug Quality Assurance2024-07-09
- VAIDrug Quality Assurance2022-07-25
- NAIDrug Quality Assurance2017-02-02
- VAIDrug Quality Assurance2014-11-21
- VAIDrug Quality Assurance2014-09-25
- VAIDrug Quality Assurance2012-07-13
- VAIDrug Quality Assurance2010-10-22
- VAIDrug Quality Assurance2008-12-05
Drugs this plant is listed as making
3 distinct drugs across 5 products name this site in their FDA label.
- Agalsidase BetaGenzyme Corporation
- olipudase alfa-rpcpGenzyme Corporation
- Thyrotropin AlfaGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.